Compare BBNX & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBNX | ANGO |
|---|---|---|
| Founded | 2015 | 1988 |
| Country | United States | United States |
| Employees | 423 | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.1M | 439.8M |
| IPO Year | N/A | 2004 |
| Metric | BBNX | ANGO |
|---|---|---|
| Price | $10.24 | $11.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $26.22 | $19.33 |
| AVG Volume (30 Days) | ★ 1.0M | 302.5K |
| Earning Date | 04-21-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.92 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | $34.99 | $9.11 |
| Revenue Next Year | $34.47 | $4.94 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $8.89 | $8.36 |
| 52 Week High | $32.71 | $13.99 |
| Indicator | BBNX | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 37.08 | 60.04 |
| Support Level | $9.91 | $11.40 |
| Resistance Level | $11.92 | $11.74 |
| Average True Range (ATR) | 0.66 | 0.37 |
| MACD | 0.14 | 0.09 |
| Stochastic Oscillator | 38.63 | 93.31 |
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.